Drotrecogin alfa (activated): a single-centre experience of 110 patients

Ítems similars

• Outcomes and incidence of bleeding events associated with drotrecogin alfa: a single-centre experience of 440 patients
  per: Boyle, A, et al.
  Publicat: (2010)
• A large, single-centre UK registry of drotrecogin alfa-activated use
  per: Macchiavello, L, et al.
  Publicat: (2007)
• Extended drotrecogin alfa (activated) therapy in patients with persistent requirement for vasopressor support after 96-hour infusion with commercial drotrecogin alfa (activated)
  per: Dhainaut, J, et al.
  Publicat: (2008)
• Increasing microcirculation after drotrecogin alfa (activated)
  per: Donati, A, et al.
  Publicat: (2007)
• Retrospective observational outcomes for drotrecogin alfa (activated)
  per: Cameron, C, et al.
  Publicat: (2007)